Critics say that the order will only shave a few months off of FDA approval, but it made Joe Rogan happy ...

Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even ...

Modern medicine has played a significant role in improving the length and quality of our lives. While many treatments may ...

When a biopharma company known for its expertise in a specific domain turns to a collaborator to expand its capabilities in that area, it serves as strong validation of the partner’s technology. It’s ...

Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual events include structured poster discussion ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

The chemistry is powered by an LED lamp that triggers a self-sustaining chain reaction, forging new carbon–carbon bonds under mild conditions without toxic or expensive chemicals. Credit: Nordin Ćatić ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.